ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$10.63 USD
-0.02 (-0.19%)
Updated May 31, 2024 04:00 PM ET
After-Market: $10.62 -0.01 (-0.09%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ALXO 10.63 -0.02(-0.19%)
Will ALXO be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ALXO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALXO
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ultragenyx (RARE) DTX401 Meets Goals in Metabolic Disorder Study
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Other News for ALXO
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
Buy Rating for ALX Oncology Amid Impressive Evorpacept and Padcev Combination Trial Results
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Mirum Pharmaceuticals (MIRM) and IDEAYA Biosciences (IDYA)
Insider Sale: Chief Medical Officer of ALX Oncology Holdings Inc (ALXO) Sells Shares
ALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A Detailed Look at Financials and ...